Status:
COMPLETED
Neural Effects of Mindfulness Training on Attention
Lead Sponsor:
University of Pennsylvania
Collaborating Sponsors:
National Center for Complementary and Integrative Health (NCCIH)
Conditions:
No Condition
Focus is Neural Effects of Mindfulness Training on Attention
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The purpose of this study is to examine behavioral and neural changes resulting from Mindfulness Meditation Training (MMT), and to use this knowledge in advancing our understanding of the mechanisms o...
Detailed Description
Mindfulness Meditation Training (MMT) has been used successfully to decrease stress, pain, and adverse health symptoms in a varied subject population. MMT has been described as "paying attention in a ...
Eligibility Criteria
Inclusion
- Men and women (all races and ethnicities) between 18 and 40 years old
- Women of childbearing age with a negative pregnancy test within 48 hours of scanning
- In good health
- Right-handed
- Normal or corrected-to-normal vision
- English as a first language
- Able to understand and provide signed informed consent
- No history of metal in their body or other reasons why they could not undergo an Magnetic Resonance Imaging
- No history of ischemic or hemorrhagic stroke, encephalopathy or encephalitis, minimal-cognitive impairment or dementia, movement disorder such as Parkinson's disease, head trauma causing loss of consciousness, cancer involving the central nervous system
Exclusion
- Pregnant or breast-feeding women
- Individuals with implanted metal or electronic devices that would prevent them from MRI scanning.
- Individuals with a history of neurologic dysfunction that would prevent performance on attentional tasks including: history of transient ischemic attacks, history of cerebral infarction, history of Binswanger's disease (or a history of hypertensive encephalopathy), history of intracranial hemorrhage, history of head trauma with loss of consciousness, history of encephalitis, history of extended exposure to any known neurotoxin, history of acquired cognitive impairment, history of normal pressure hydrocephalus, history of a cancer metastatic to the central nervous system, history of Parkinson's or other basal ganglia disease, history of Guillain-Barré syndrome or chronic or relapsing polyneuropathy
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00379210
Start Date
September 1 2006
End Date
August 1 2009
Last Update
January 26 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104